October 16, 2026

Former senior FDA official and Medtronic executive brings extensive regulatory, clinical and industry experience to Numerof clients

Numerof & Associates, a healthcare strategy consulting firm advising organizations across the life sciences ecosystem, today announced that Susan Alpert, PhD, MD, former senior executive at the U.S. Food and Drug Administration (FDA) and Medtronic, has joined the firm as a Senior Consultant and Engagement Manager. Dr. Alpert brings extensive experience in regulatory strategy, product development and global market entry with which to help clients navigate today’s increasingly complex regulatory and commercialization challenges.

Dr. Alpert will collaborate with Numerof’s senior advisory team to help clients develop regulatory strategies, engage effectively with the FDA, evaluate pathways for innovative products and align regulatory requirements with broader product development and commercialization objectives.

“Susan brings a rare combination of experience as a senior FDA decision-maker, a global regulatory executive and a practicing physician,” said Rita E. Numerof, PhD, President and co-founder of Numerof & Associates. “Her understanding of how regulatory decisions are made, coupled with her experience navigating these challenges from an industry perspective, will be enormously valuable to clients seeking to bring innovative medical products to market. We are delighted to welcome her to our team.”

Dr. Alpert’s career spans senior leadership positions at the FDA, C.R. Bard and Medtronic. During her tenure at the FDA, she held management positions across several Centers responsible for drugs, medical devices and radiological health, and foods. From 1993 to 1999, she served as Director of the Office of Device Evaluation, overseeing the FDA organization responsible for evaluating medical devices prior to their introduction into the U.S. market.

Following her FDA service, Dr. Alpert joined C.R. Bard as Vice President of Regulatory Sciences. In 2003, she joined Medtronic as Vice President of Regulatory Affairs and Compliance and subsequently became Corporate Senior Vice President for Global Regulatory Affairs, with responsibility for the company’s global regulatory policy activities. She retired from Medtronic in 2011.

Since then, Dr. Alpert serves as Principal of SFADC LLC, advising companies on strategies for bringing medical devices and other healthcare products to global markets. In recent years, she has worked with more than a dozen companies pursuing FDA Breakthrough Device designation and participation in the Safer Technologies Program (STeP). She has also participated in numerous FDA Pre-Submission meetings supporting the development of drugs, biologics and medical devices.

“I am pleased to join Numerof & Associates and contribute to the firm’s work helping healthcare innovators address the challenges of bringing new products to market,” said
Dr. Alpert. “Regulatory strategy is most effective when it is integrated with clinical development, evidence generation and commercialization planning. I look forward to working with the Numerof team to help clients navigate these interconnected challenges and bring valuable innovations to patients.”

The addition of Dr. Alpert brings together her extensive regulatory, scientific and clinical expertise with Numerof’s capabilities in strategic planning, evidence generation, market access, commercialization strategy and organizational transformation. Her experience will help clients address regulatory considerations as an integral part of broader business and product development decisions.

A trained microbiologist and pediatrician specializing in infectious diseases, Dr. Alpert earned her undergraduate degree from Barnard College, Columbia University, master’s and PhD degrees in Biomedical Sciences from New York University, and her medical degree from the University of Miami. She serves on several nonprofit and for-profit boards and is an Executive in Residence at the Medical Industry Leadership Institute at the University of Minnesota’s Carlson School of Management.

About Numerof & Associates
Numerof & Associates is a strategy consulting firm that develops customized, market-based solutions for the strategic and operational challenges of organizations in industries undergoing significant transition. Working globally across the healthcare industry with clients in pharmaceuticals, medical devices and diagnostics, payers, and healthcare delivery, Numerof brings a unique cross-disciplinary approach to a broad range of engagements designed to sharpen strategic focus, increase revenues, reduce costs and risk, and enhance customer value.

Visit nai-consulting.com and connect with us on LinkedIn and X.

Media Contact:
Jamie Shearer
Senior Account Executive, Pinkston
571.405.1606
numerof@pinkston.co